Memphasys Company Description

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia.

The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes.

It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port, an ambient temperature semen transport device for artificial insemination in animals.

In addition, the company develops ambient temperature storage product for human sperm; and a medium for human sperm isolation, fertilisation and cryopreservation.

Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.

Memphasys Limited

Country	Australia
Founded	2006
Industry	Biological Products, Except Diagnostic Substances
Employees	24
CEO	David Ali

Contact Details

Address: 34-36 Richmond Road Homebush, New South Wales 2140 Australia
Phone	61 2 8415 7300
Website	memphasys.com

Stock Details

Ticker Symbol	IG7
Exchange	Frankfurt Stock Exchange
Fiscal Year	July - June
Reporting Currency	AUD
SIC Code	2836

Key Executives

Name	Position
David Ali	Chief Executive Officer
Pablo Neyertz	Chief Financial Officer
Hassan Bakos	Chief Operating Officer